The occurrence of an angiosarcoma in the adrenal gland is exceedingly rare as only 21 patients have been reported in the literature since its first description 30 years ago. We report the clinicopathological features of a 34-year-old patient presenting with overt Cushing’s syndrome due to a ACTH-secreting pituitary adenoma and an adrenal spindle cell angiosarcoma. This association made the diagnosis of Cushing’s disease particularly puzzling in view of the results of biochemical tests which were compatible in part with adrenal and in part with paraneoplastic hypercortisolism and the negative pituitary imaging. The unique appearance of this tumor and its diagnostic implications are discussed.

Keywords:
Angiosarcoma, Adrenal cortex, ACTH, Cushing’s syndrome, Cushing’s disease
1.
Invitti C, Pecori Giraldi F, De Martin M, Cavagnini F, the Study Group of the Italian Society of Endocrinology on the Pathophysiology of the Hypothalamic-Pituitary-Adrenal Axis: Diagnosis and management of Cushing’s syndrome: Results of an Italian multicentre study. J Clin Endocrinol Metab 1999;84:440–448.
2.
Abecassis M, McLoughlin MJ, Langer B, Kudlow JE: Serendipitous adrenal masses: Prevalence, significance and management. Am J Surg 1985;149:783–788.
3.
Kloos RT, Gross MD, Francis IR, Korobkin M, Shapiro B: Incidentally discovered adrenal masses. Endocr Rev 1995;16:460–484.
4.
Pecori Giraldi F, Cavagnini F: Corticotropin-releasing hormone is produced by rat corticotropes and modulates ACTH secretion in a paracrine/autocrine fashion. J Clin Invest 1998;101:2478–2484.
5.
Latronico AC, Chrousos GP: Adrenocortical tumors. J Clin Endocrinol Metab 1997;82:1317–1324.
6.
Carney JA, Young WF: Primary pigmented nodular adrenocortical disease and its associated conditions. Endocrinologist 1992;2:6–21.
7.
Stratakis CA, Sarlis N, Kirschner L, Carney JA, Doppman JL, Nieman LK, Chrousos GP, Papanicolaou DA: Paradoxical response to dexamethasone in the diagnosis of primary pigmented nodular adrenocortical disease. Ann Intern Med 1999;131:585–591.
8.
Sarlis N, Chrousos GP, Doppman JL, Carney JA, Stratakis CA: Primary pigmented nodular adrenocortical disease: Re-evaluation of a patient with Carney complex 27 years after unilateral adrenalectomy. J Clin Endocrinol Metab 1997;82:1274–1278.
9.
Slyper AH, Findling JW: Use of a two-site immunoradiometric assay to resolve a factitious elevation of ACTH in primary pigmented nodular adrenocortical disease. J Pediatr Endocrinol 1994;7:61–63.
10.
Young J, Deneux C, Grino M, Oliver C, Chanson P, Schaison G: Pitfall of petrosal sinus sampling in a Cushing’s syndrome secondary to ectopic adrenocorticotropin-corticotropin releasing hormone secretion. J Clin Endocrinol Metab 1998;83:305–308.
11.
Ozawa Y, Tomoyasu H, Takeshita A, Shishiba Y, Yamada S, Kovacs K, Matushita H: Shift from CRH to ACTH production in a thymic carcinoid with Cushing’s syndrome. Horm Res 1996;45:264–268.
12.
Suda T, Kondo M, Totani R, Hashimoto N, Suzuki M, Imaki T, Oba Y, Tomori N, Yajima F, Sumitomo T, Nakagami Y, Ushiyama T, Demura H, Shizume K: Ectopic adrenocorticotropin syndrome caused by lung cancer that responded to corticotropin-releasing hormone. J Clin Endocrinol Metab 1986;63:1047–1051.
13.
Mantero F, Terzolo M, Arnaldi G, Osella G, Masini AM, Alì A, Giovagnetti M, Opocher G, Angeli A, the Study Group on Adrenal Tumors of the Italian Society of Endocrinology: A survey on adrenal incidentaloma in Italy. J Clin Endocrinol Metab 2000;85:637–644.
14.
Lee JE, Evans DB, Hickey RC, Sherman SI, Gagel RF, Abruzzese MC, Abruzzese JL: Unknown primary cancer presenting as an adrenal mass: Frequency and implications for diagnostic evaluation of adrenal incidentalomas. Surgery 1998;124:1115–1122.
15.
Enzinger F, Weiss SW: Soft Tissue Tumors, ed 3. St Louis, Mosby, 1993.
16.
Kern WH, Smart RH, Sherwin RP: Angiosarcoma of lungs and adrenal gland. Minn Med 1967;50:1339–1343.
17.
Donald D: Malignant haemangio-endothelioma associated with congenital adrenal hyperplasia. J Pathol 1972;109:361–363.
18.
Radaszkiewiez T, Pantueek F, Kieler A: Malignant hemangioendothelioma of adrenal gland and its histogenesis. Zentralbl Allg Pathol 1975;119:364–368.
19.
Nakagawa N, Takahashi M, Maeda K, Fujimura N, Yufu M: Case report: Adrenal haemangioma coexisting with malignant haemangioendothelioma. Clin Radiol 1986;37:97–99.
20.
Kareti LR, Katlein S, Siew S, Blauvelt A: Angiosarcoma of the adrenal gland. Arch Pathol Lab Med 1988;112:1163–1165.
21.
Livaditou A, Alexiou G, Floros D, Filippidis T, Dosios T, Bays D: Epithelioid angiosarcoma of the adrenal gland associated with chronic arsenical intoxication? Pathol Res Pract 1991;187:284–289.
22.
Bosco PJ, Silverman ML, Zinman LM: Primary angiosarcoma of adrenal gland presenting as paraneoplastic syndrome: Case report. J Urol 1991;146:1101–1103.
23.
Ben-Izhak O, Auslander L, Rabinson S, Lichtig C, Sternberg A: Epithelioid angiosarcoma of the adrenal grand with cytokeratin expression. Cancer 1992;69:1808–1812.
24.
Fiordelise S, Zangrandi A, Tronci A, Rovereto B, Valentino RV, Bezzi E: Angiosarcoma of the adrenal gland. Case report. Arch Ital Urol 1992;64:341–343.
25.
Jochum W, Schröder S, Risti B, Marincek B, von Hochsetter A: Cytokeratin-positive angiosarcoma of the adrenal. Pathologe 1994;15:181–186.
26.
Schwenk W, Sarbia M, Haas R, Stock W: Primary haemangiosarcoma, a rare form of an incidental adrenal mass. Dtsch Med Wochenschr 1994;119:217–221.
27.
Wenig BM, Abbondanzo SL, Heffess CS: Epithelioid angiosarcoma of the adrenal glands. Am J Surg Pathol 1994;18:62–73.
28.
Sasaki R, Tachiki Y, Tsukada T, Kiura K, Kato T, Saito K: A case of adrenal angiosarcoma. Nippon Hinyokika Gakkai Zasshi 1995;86:1064–1067.
29.
Grimaldi F, Cagol PP, Pasqual EM, Purinan A, Scott C, Bertolissi F: Adrenal angiosarcoma: A case report (abstract). J Endocrinol Invest 2000;23(suppl 6):180.
© 2002 S. Karger AG, Basel
2002
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.